Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2015 02:17 ET | Source: Esperite N.V.

:ESPERITE (ESP) adquiere InKaryo, una "start-up" estadounidense especializada en Bioinformática para el diagnóstico genético y tests citogenéticos moleculares

ESPERITE refuerza sus tests genéticos para liderar el mercado con eKaryotype, el test electrónico del genoma total Karyotype. ESPERITE da la bienvenida a Xitong li, Ph.D., anterior Director de...
March 19, 2015 02:17 ET | Source: Esperite N.V.

Esperite (ESP) acquista InKaryo, start-up USA specializzata in Bioinformatica per la diagnostica genetica ed i test di citogenetica molecolare

ESPERITE rafforza la sua offerta verso il top del mercato dei test diagnostici con eKaryotype, il test elettronico del Cariotipo dell'intero Genoma. Entra a far parte del Team ESPERITE, Xitong li,...
March 19, 2015 02:17 ET | Source: Esperite N.V.

Η ESPERITE (ESP) εξαγοράζει την InKaryo, μια Αμερικάνικη start-up που εξειδικεύεται στην Βιοπληροφορική στον τομέα της γενετικής διαγνωστικής και των δοκιμασιών μοριακής κυτταρογενετικής.

Η ESPERITE ενισχύει το χαρτοφυλάκιο των διαγνωστικών τεστ της στοχεύοντας στην κορυφή της αγοράς με το eKaryotype, μια ηλεκτρονική δοκιμασία καρυότυπου ολόκληρου γονιδιώματος. Η Esperite καλωσορίζει...
March 19, 2015 02:17 ET | Source: Esperite N.V.

ESPERITE (ESP) acquires InKaryo, US start-up specialised in Bioinformatics for genetic diagnostics and molecular cytogenetic tests

ESPERITE's strengthens its diagnostic tests to top the market with eKaryotype, electronic whole-genome Karyotype test. Esperite welcomes Xitong li, Ph.D., ex-Verinata Illumina Director of...
March 19, 2015 02:17 ET | Source: Esperite N.V.

ESPERITE (ESP) acquires InKaryo, US start-up specialised in Bioinformatics for genetic diagnostics and molecular cytogenetic tests

ESPERITE's strengthens its diagnostic tests to top the market with eKaryotype, electronic whole-genome Karyotype test. Esperite welcomes Xitong li, Ph.D., ex-Verinata Illumina Director of...
March 17, 2015 02:17 ET | Source: Esperite N.V.

ESPERITE (ESP) financial results for 2014 published, metamorphosis completed, first positive forecast growth at €36mio Revenues (+30%) for 2015

ESPERITE ("Esperite N.V. (Euronext: ESP, "ESPERITE" or "the Company") strengthens market position of Genoma with acquisitions of exclusive technologies for fully-certified groundbreaking genetic...
March 17, 2015 02:17 ET | Source: Esperite N.V.

ESPERITE (ESP) financial results for 2014 published, metamorphosis completed, first positive forecast growth at €36mio Revenues (+30%) for 2015

ESPERITE ("Esperite N.V. (Euronext: ESP, "ESPERITE" or "the Company") strengthens market position of Genoma with acquisitions of exclusive technologies for fully-certified groundbreaking genetic...
March 16, 2015 02:17 ET | Source: Esperite N.V.

Esperite (ESP) et Premaitha Health signent un accord de collaboration pour la réalisation de tests NIPT en Europe

Manchester, Royaume-Uni et Zutphen, Hollande - 16 Mars 2015 - Premaitha Health plc ("Premaitha", AIM: NIPT) et Esperite NV ("Esperite", AMS:ESP, Zutphen, Hollande) annoncent aujourd'hui la signature...
March 16, 2015 02:17 ET | Source: Esperite N.V.

Esperite (ESP) and Premaitha Health sign a collaboration agreement for NIPT provision in Europe

Manchester, UK and Zutphen, the Netherlands - 16 March 2015 - Premaitha Health plc ("Premaitha", AIM: NIPT) and Esperite NV ("Esperite", AMS: ESP, Zutphen, the Netherlands) today announce the...
February 23, 2015 11:58 ET | Source: Esperite N.V.

ESPERITE 2,154,000 shares exchanged today. Thank you for your interest in our company

Geneva, Switzerland - 23 February 2015 ESPERITE (ESP) 2'154'000 shares EXCHANGED TODAY. THE COMPANY publishes this note of appreciation addressed to all the investors who massively increased the...